The Diverticulitis market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2019 to 2032. It evaluates the current treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Get the PDF Sample of the Report:- Diverticulitis Market Analysis
Diverticulitis: An Overview
Diverticulitis is a digestive condition that affects the large intestine (bowel). Diverticulosis is a condition that occurs when small pouches, or sacs, form and push outward through weak spots in the wall of the colon. Diverticulitis occurs when one has diverticulosis and one or a few of the pouches in the wall of the colon become inflamed.
In diverticulitis, the inflamed pouches most often cause pain in the lower left side of the abdomen. The pain is usually severe and comes on suddenly, though it can also be mild and get worse over several days. The intensity of the pain can change over time.
According to the NIDDK, about 70,000 people are hospitalized for diverticular bleeding each year. Experts used to think that 10 to 25 % of people with diverticulosis would develop diverticulitis. However, newer research suggests that the percentage who develop diverticulitis may be much lower—less than 5 percent. diverticulitis by 26% from 1998 to 2005.
Diverticulitis market size shall grow during the forecast period owing to the launch of upcoming therapies and an increased patient pool. Of the emerging therapies, the most anticipated product to get launched is Aemcolo and Endari. The pipeline for Diverticulitis- though not very vast - provides an opportunity for other key players to hold a great share in the market
The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Diverticulitis market size and share by analyzing the impact of current and emerging therapies on the market. It also provides a detailed assessment of the unmet needs, market drivers barriers, and emerging technologies.
The report gives a thorough detail of the Diverticulitis market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Diverticulitis Epidemiology
The epidemiology section covers insights about the historical and current Diverticulitis patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Diverticulitis Epidemiology Segmentation
-
Total Prevalent Cases of Diverticulitis
-
Gender-specific Prevalent Cases of Diverticulitis
-
Diagnosed and Treatable Cases of Diverticulitis
-
Age-specific Prevalent Cases of Diverticulitis
Diverticulitis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Diverticulitis market or expected to get launched in the market during the study period. The analysis covers Diverticulitis market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The report also covers the Diverticulitis Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.
Diverticulitis Therapeutics Market Analysis
The dynamics of the Diverticulitis market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the diseases, incremental healthcare spending across the world, and also expects the launch of emerging therapies during the forecast period.
Some of the key companies in the Diverticulitis Market include:
-
Emmaus Medical
-
Cosmo Pharmaceuticals
And many others
Diverticulitis Therapies covered in the report include:
-
Aemcolo
-
Endari
And many more
Get More Detailed Insights into the Emerging Therapies & Key Companies: https://www.delveinsight.com/sample-request/diverticulitis-market
Table of Content
1. Key Insights
2. Executive Summary
3. Diverticulitis Competitive Intelligence Analysis
4. Diverticulitis Market Overview at a Glance
5. Diverticulitis Disease Background and Overview
6. Diverticulitis Patient Journey
7. Diverticulitis Epidemiology and Patient Population
8. Diverticulitis Treatment Algorithm, Current Treatment, and Medical Practices
9. Diverticulitis Unmet Needs
10. Key Endpoints of Diverticulitis Treatment
11. Diverticulitis Marketed Products
12. Diverticulitis Emerging Therapies
13. Diverticulitis Seven Major Market Analysis
14. Attribute Analysis
15. Diverticulitis Market Outlook (7 major markets)
16. Diverticulitis Access and Reimbursement Overview
17. KOL Views on the Diverticulitis Market.
18. Diverticulitis Market Drivers
19. Diverticulitis Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Request Sample Report here:- https://www.delveinsight.com/sample-request/diverticulitis-market
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email:Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
